Navigation Links
Increase in renal problems

The cognitive problems that can occur in patients with chronic renal failure might be alleviated by certain antioxidants, say US researchers. Scientists at the University of California, Irvine, found that rodent models of chronic renal failure had higher levels of nitrotyrosine,// a marker of oxidative damage caused by the interaction of oxygen free radicals with nitric oxide, in areas of their cerebral cortex than healthy control rats.

However, by treating the rats with kidney failure with an antioxidant called des-methyl-tirilizad, the scientists were able to lower the levels of molecules responsible for the oxidative stress. “This study shows how free radicals and nitric oxide interact to produce oxidative stress and help cause these neurological dysfunctions,” said Dr Nick Vaziri, head of the research. “It also may provide a way to treat these disorders,” he said.

Dr Vaziri suggested that it might be possible to link the results with similar events that occur in the nervous system in other disorders, such as in Huntington’s and Alzheimer’s disease. “However, more studies are needed to determine if this could be useful in humans,” he said.

The researchers are hopeful that antioxidants might be used in the future to treat, or even to prevent, cognitive dysfunction. An estimated 100,000 people in the UK suffer from some form of kidney disease, excluding cystitis and kidney stones, with renal failure leading to about 7,000 deaths in the UK each year.

'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Increase in sugar...decrease in brain function!!!
3. Increase in tobacco deaths
4. Increased Heart Attack Risk From Celebrex,Vioxx
5. Deep Sleep Doesnt Increase Memory
6. Allergy Risk Increased by Kerosene Use
7. IVF technique May Increase The Risk Of Birth Defects
8. Step Aerobics Increases good cholesterol
9. Fewer teeth & Increased Ischemic Stroke risk
10. Painkillers Increase Risk of Miscarriage
11. Diabetes on the Increase but Death Rate Falling
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: